V. Manchev

A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene.

M. Bryckaert, W. Vainchenker, N. Debili, 2014, Blood.

Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity

P. Duchateau, L. Poirot, O. Danos, 2014, Gene Therapy.

Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre‐leukaemic clone resulting in T2‐ALL and AML‐M0

W. Vainchenker, R. Favier, H. Raslova, 2016, Journal of cellular and molecular medicine.

Acquired TET 2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T 2-ALL and AML-M 0

W. Vainchenker, H. Raslova, E. Macintyre, 2017 .

ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis

A. Balduini, N. Balayn, W. Vainchenker, 2022, bioRxiv.

Phase variable genes of Campylobacter jejuni exhibit high mutation rates and specific mutational patterns but mutability is not the major determinant of population structure during host colonization

M. V. Tretyakov, J. Ketley, Jean-Philippe Grossier, 2012, Nucleic acids research.

Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.

D. Bluteau, N. Balayn, E. Solary, 2015, Blood.